JD(U) attacks NDA govt over drug pricing issue

Image
Press Trust of India New Delhi
Last Updated : Oct 10 2014 | 7:28 PM IST
Hitting out at the NDA government, JD(U) today said the decision to de-control prices of life-saving drugs was "inhuman" and showed that the centre was not concerned about the common man.
Speaking to newspersons here, JD(U) President Sharad Yadav alleged that the National Pharmaceutical Pricing Authority (NPPA) had withdrawn the order, which kept these essential drugs under control, just before Prime Minister Narendra Modi's visit to the US.
"I am worried that the life-saving drugs have become expensive and are beyond the reach of the common man in the country... NPPA had withdrawn the order whereby the essential life-saving drugs were kept under control just before Prime Minister's US visit.
"After lifting the control on the prices of these medicines, the rates are increasing by leaps and bounds as a result of which these medicines will become beyond the reach of the common man," he said.
Yadav alleged that the government was waiting for the assembly elections in some states to get over after which it was going to "announce certain decisions which will further hit the poor people".
"It is inhuman on the part of the government to de-control prices of 108 life-saving drugs which are used by patients of heart, cancer, T.B, diabetes, HIV, and for respiratory diseases," he said.
"In a nutshell, the present government is unconcerned and not worried about the livelihood of common and poor people of this country," Yadav added.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 10 2014 | 7:28 PM IST

Next Story